Table 1.

Schedule for treatment and outcome measurement

Item	Screening	Treatment															Follow-up
Session	1 (baseline)	2	3	4	5	6	7	8	9	10	11	12	13	14	15	16	17 (+1 m)	18 (+2 m)	19 (+3 m)
Eligibility screening	√
Informed consent	√
Patient preference screening	√
Allocation	√
Patient expectation toward treatment	√
Treatment		√	√	√	√	√	√	√	√	√	√	√	√	√	√	√
Widespread pain index	√					√					√					√	√	√	√
Symptom severity	√					√					√					√	√	√	√
Visual analogue score	√					√					√					√	√	√	√
Fibromyalgia intensive questionnaire	√															√	√	√	√
Hamilton depression scale	√															√	√	√	√
SF-36 Health survey	√															√	√	√	√
Patient satisfaction of treatment																√
Number of dropouts or lost to follow-up																√			√
Practitioner attitude toward research model																√			√
Recording of adverse events	√	√	√	√	√	√	√	√	√	√	√	√	√	√	√	√	√	√	√